1. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006; 73(7):1211–1220. PMID:
16623208.
2. Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020; 16(12):702–714. PMID:
32939060.
Article
3. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020; 79(1):77–87. PMID:
31796497.
Article
4. Kim HW, Kim KH, Shin AY, Choi JY, Ahn JH, Kim JS, et al. Investigating the appropriate adenosine deaminase cutoff value for the diagnosis of tuberculous pleural effusion in a country with decreasing TB burden. Sci Rep. 2022; 12(1):7586. PMID:
35534515.
Article
5. Jeon D. Tuberculous pleurisy: an update. Tuberc Respir Dis (Seoul). 2014; 76(4):153–159. PMID:
24851127.
Article
6. Doita S, Tamura T, Baba T, Oomori H, Nishii K, Nakanishi M, et al. A case of immunoglobulin G4-related disease with pleural effusion, requiring exclusion of tuberculous pleurisy. Respir Med Case Rep. 2022; 37:101654. PMID:
35540692.
Article
7. Bagcchi S. WHO’s global tuberculosis report 2022. Lancet Microbe. 2023; 4(1):e20. PMID:
36521512.
Article
8. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013; 368(8):745–755. PMID:
23425167.
Article
9. Ryan H, Yoo J, Darsini P. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. 2017; 3(3):CD001876. PMID:
28290161.
Article